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Abstract
Behçet’s disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology. Oral 
and genital aphthous ulcers are considered as the hallmarks of BD. The genital ulcers of BD 
may be extremely painful and often refractory to multiple treatments. In addition, they exert 
a negative impact on the patient’s quality of life. Some investigations have demonstrated the 
significant and immediate pain-relieving effects of NTCLT (non-thermal CO2 laser therapy) 
on some oral lesions with no visible adverse effects. In this paper, we report a case of BD 
whose painful genital ulcers were irradiated with NTCLT and the patient’s pain caused by the 
ulcers relieved immediately and significantly with no visible complications.
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Introduction
Behçet’s disease (BD) is a chronic, systemic vasculitis 
which can affect almost all vascularized systems. BD has 
a chronic, relapsing course, progressing by attacks and 
remissions.1-6 It is most common in the countries along 
the “ancient Silk Road” with the highest prevalence in 
Japan, China, Korea, Iran and Turkey.7 Mucocutaneous 
lesions are considered as the hallmarks of BD. Genital 
ulcers which develop in 57%-93% of the patients6 are 
punched-out ulcers with a white yellowish necrotic base, 
surrounded with an erythematous halo. These lesions 
morphologically resemble oral aphthous ulcers; however, 
they are usually larger, deeper, more painful, heal more 
slowly and recur less frequently with a much more scarring 
tendency.4,8 These ulcers may be giant, destructive and 
refractory to multiple treatments. The severe and giant 
ulcers may even lead to vulva destruction.9 These ulcers 
may be extremely painful with a negative impact on the 
patient’s quality of life.9,10 It is quite rational to develop 
new therapeutic approaches for pain control of the genital 
lesions of BD during conventional systemic therapy.
Photobiomodulation (low-level laser or light therapy, 
LLLT, or laser phototherapy) is an efficient, non-invasive 
therapeutic option used to reduce pain, stimulate wound 
healing, and reduce inflammation.
The CO2 laser as a valuable high-power thermal laser 
has been widely used in surgery for decades. Some studies 
have established that CO2 laser can also be applied as a low-
level (photobiomodulative) laser to achieve immediate 
and significant pain relief in some oral lesions without 
any visible thermal complications even erythema.11-18 This 
process has been pain-free with no need for anesthesia. 
No kind of thermal complications have been observed 
after laser treatment. In this procedure, the rapid scan 
of the lesion with the defocused laser handpiece and 
the irradiation of the lesions through a thick layer of gel 
containing high water lead to a significant reduction in the 
final beam power at the surface of the lesion to the range 
of low-level phototherapeutic lasers.13 This procedure, 
which was initially called non-ablative CO2 laser therapy 
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(NACLT), was termed non-thermal CO2 laser therapy 
(NTCLT) afterwards to avoid its confusion with fractional 
non-ablative CO2 lasers used for skin rejuvenation. In this 
paper, we report a case of BD whose painful giant genital 
aphthous ulcers responded to the analgesic effects of 
NTCLT immediately and dramatically.
Case Report 
A 23-year-old female patient with giant, extremely painful 
genital aphthous ulcers of one month’s duration was 
referred from hospital to our clinic for pain reduction in 
her genital lesions by NTCLT. There were giant, extremely 
painful aphthous ulcers in her vulva (Figure 1). The ulcers 
were so painful, which disturbed her physical activities 
such as sitting, walking, sleeping, and especially urinating 
with a great influence on her quality of life. The severe pain 
of the lesions didn’t respond to the conventional analgesic 
agents. The non-contact visual analogue scale (VAS) pain 
scores of the right-sided and left-sided genital ulcers were 
6 and 8 respectively. The contact pain in the ulcers of both 
sides was 10. Histologically, a biopsy specimen taken from 
the genital lesion revealed diffuse dense infiltration with 
neutrophilic predominance and multiple focal abscesses 
composed of lymphocytes, eosinophils, and nuclear dusts. 
There were vascular proliferation, endothelial swelling, 
and thickening of blood vessel walls (Figure 2). 
She fulfilled the International Criteria for Behcet’s 
Disease (ICBD) with a 5-year history of recurrent 
oral aphthous ulcers with high frequency, a positive 
pathergy test, and genital aphthous ulcers. The patient 
was hospitalized and referred to our service for pain 
relief of her genital ulcers by NTCLT. Before signing the 
informed consent, she was briefed on the process and 
its investigational nature. She was advised that NTCLT 
might have an impact only on pain reduction in her 
genital lesions with no beneficial effect on the natural 
history of her disease. She was also well informed about 
the necessity of continuing her systemic treatment. 
To perform the NTCLT procedure, at first, the lesion 
and its surrounding tissue were covered with a thick (3-4 
mm) layer of high water content (87.5%), transparent, 
non-anesthetic gel. The patient and the surgical staff used 
protective eyeglasses during NTCLT. The CO2 laser beam 
(λ = 10 600 nm; Lancet-2, Russia) was illuminated (power: 
1 W, continuous mode with a de-focused handpiece, 5–6 
mm distant from the mucosal surface, and a rapid scan 
over the lesion with a circular motion) through the gel. In 
any part of the lesion, the laser beam was irradiated to a 
circle area of the ulcer (with a diameter of approximately 1 
cm) for 5 seconds in each pass and repeated immediately 
if the contact pain of the lesion persisted. In any part of 
the lesions, between the passes, the prior gel was wiped 
gently and a new layer of gel was placed on the lesion to 
prevent a reduction in the water content of the gel and a 
tissue burn. 
Immediately after NTCLT, the pain of the lesions 
relieved, so that she could even walk up and downstairs 
with no problems. No kind of thermal adverse effects such 
as destruction, ablation or aggravation of the lesions was 
observed following NTCLT. The procedure was painless 
and anesthesia was not required. This analgesic effect 
continued during the healing period of the ulcers. She 
reported no problem in daily functions and required no 
analgesics. She just reported mild burning with urination 
for the first 3-4 days. Treatment with prednisolone 30 
mg and colchicine 2 mg was started after result of biopsy 
(one day after NTCLT. It was interesting to observe that 
the depth of the genital ulcers slightly decreased just 2 
days after NTCLT. The healing period of the ulcers was 
about 9-11 days, which seemed to be shorter than what 
was expected. She was discharged from the hospital with 
prednisolone 25 mg and colchicine 2 mg daily. She was 
visited every 2 weeks for 2 months. She had no problem or 
sensory loss in the laser-treated areas. The ulcers healed 
with a very fine scar in spite of the giant size of the ulcers 
(Figure 3B). 
Six months later, she was referred to our service again 
for pain reduction in her new genital aphthous ulcer by 
NTCLT. She had discontinued her medications one month 
before arbitrarily because of poor compliance (Figure 3). 
The use of prednisolone 30 mg and colchicine 2mg daily 
was initiated again for her in the hospital. The non-contact 
and contact VAS pain scores of the ulcer were 6 and 8 
respectively. The pain of the lesions eased immediately. 
Figure 1. The Patient’s Genital Aphthous Ulcer Before NTCLT.
Figure 2. Histological Feature of the Patient’s Genital Aphthous Ulcer.
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Similar to the first NTCLT session, anesthesia was 
not required and there was no complication following 
NTCLT. The ulcer healed completely within five days. 
It was interesting to notice that prior giant genital ulcers 
which had been already irradiated with NTCLT had left 
excellent cosmetic results with very fine scars (Figure 
3). The patient was discharged from the hospital with 
prednisolone 20 mg and colchicine 2 mg daily. She was 
visited every two weeks for up to three months. She had 
no visible side effects or sensory deficits in the NTCLT-
treated areas. 
She returned to our laser department because of a 
minor relapse of the genital ulcer in spite of continuing 
systemic treatment after one year. No scar was observed 
at the site of her last year’s genital ulcer. The non-contact 
and contact VAS pain scores of her new genital ulcer were 
3 and 6 respectively. NTCLT was performed and the pain 
of her lesions eased immediately with no complications. 
Discussion 
The results of this case report propose that NTCLT 
(as a photobiomodulative laser) could be potentially 
considered as an alternative option for immediate and 
significant pain relief in genital aphthous ulcers of BD 
with no complications. 
Photobiomodulation has been used as a safe and 
valuable option for pain relief, improving the wound 
healing process and anti-inflammatory effects. In addition 
to the conventional photobiomodulative lasers (such as 
semiconductor lasers), surgical lasers can also be applied 
for photobiomodulation. As Tuner stated, “when high 
power lasers are used for biomodulation, one only needs 
to make the beam wide enough not to burn. An alternative 
is to scan rapidly over the lesion with a narrow beam. 
Therefore, the power density or average power is kept 
low enough to avoid burning, and their incident energy 
and power density are set within the low intensity laser 
therapy range”. The exciting experiment of Endre Mester 
with a low-powered ruby laser illumination on the shaved 
skin of the mice and faster regrowth of the hairs can be 
regarded as the primary evidence of photobiomodulation 
by a surgical laser.19,20 
Some articles highlighting the pain-relieving effects of 
non-thermal CO2 laser irradiation in some oral lesions 
have been published.11-18 In order to apply the high power, 
a surgical CO2 laser as a low-power, photobiomodulative 
instrument for NTCLT, rapid scanning of the lesion with 
the defocused laser handpiece, and the illumination of the 
lesions through a thick layer of gel containing high water 
reduces the final beam power at the surface of the lesion 
by a factor of 200-500.13 By these amounts of attention, the 
CO2 laser has been used as a photobiomodulative laser to 
achieve immediate and significant pain relief (P < 0.001) 
in some oral lesions with no adverse effects.11-18 Following 
careful application of NTCLT, the patients have reported 
no warmth in their lesions during NTCLT and there have 
been no reports of thermal adverse effects on the oral 
mucosa or the aggravation of the existing lesions.11-18 This 
laser technique was initially termed NACLT, but after 
proving its non-thermal nature, it was called NTCLT 
to avoid its confusion with high-power fractional non-
ablative CO2 lasers used for skin rejuvenation. In fact, 
NTCLT as a valuable photobiomodulative protocol is quite 
different from traditional surgical CO2 laser application 
and should not be mistaken for fractional non-ablative 
CO2 lasers which are thermal, high power lasers too. 
In order to help the protection of the physician’s eyes 
against the reflected beam from the surface of the gel, 
we highly recommend the physicians to wear eyeglasses 
not only matched to the 10 600 nm wavelength, but also 
matched to the wavelength of the guiding beam of the 
laser. 
The results of this report propose that NTCLT could be 
potentially considered as a promising laser technique for 
immediate and remarkable pain relief of genital aphthous 
ulcers of caused by BD with no visible thermal side 
effects. Regardless of the giant size of the genital ulcers 
of the patient on the first visit, they healed sooner than 
was supposed and left excellent cosmetic results with 
a very fine scar (Figure 3). The anti-inflammatory and 
accelerating effects of conventional photobiomodulation 
therapies on wound healing have been demonstrated.21-25 
Although in a pilot RCT, Zand et al suggested the 
accelerating effects of NTCLT on wound healing of minor 
aphthous ulcers, the pain-relieving effect of NTCLT (P 
<0.001) was much more significant than its promoting 
healing effects on miRAS (P = 0.02).17 
Since BD is a serious multisystem disease with long-
term mortality and morbidity, the patients should be 
warned that in spite of the immediate and significant 
analgesic effects of NTCLT, they should continue their 
conventional systemic treatment of their disease. The 
absence of previous reports describing such an analgesic 
effect on genital aphthous ulcers of BD makes this report 
of special interest to dermatologists, rheumatologists, 
and gynecologists. Well-designed controlled studies with 
Figure 3. (A) The new genital aphthous ulcer, (B) Notice to the fine scar of 
the prior giant genital ulcer which had already been irradiated with NTCLT.
Journal of Lasers in Medical Sciences  Volume 11, Number 1, Winter 2020 111
                                                                                 Non-Thermal CO2 Laser in Genital BD Ulcers
appropriate sample sizes are clearly required to confirm 
the analgesic effect of NTCLT on genital aphthous ulcers 
of BD. These kinds of trials will also be able to find out 
whether NTCLT can optimize the wound healing process 
and prevent scar formation in these lesions or not. In 
addition, such studies will determine whether or not 
additional NTCLT sessions are necessary for pain relief 
and accelerating wound healing in genital aphthous 
ulcers of BD (especially the giant lesions). 
Furthermore, we recommend that, in further clinical 
studies, the analgesic effects of NTCLT and conventional 
photobiomodulative lasers (such as diode
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